CONTACT US
Search
Immunotherapy designed
to combat cancer

IDM Pharma is a biopharmaceutical company focused on the development of innovative products that activate the immune system to treat cancer.

We are currently developing two types of products designed to:

Destroy cancer cells by activating innate immunity
Prevent tumor recurrence by triggering a specific adaptive immune response

learn more >>

 
Latest News

05/18/2009

Takeda to Acquire IDM Pharma, Adding MEPACT(R) (Mifamurtide), the First Treatment Approved for Osteosarcoma in More Than 20 Years, to Its Oncology Franchise

05/11/2009

IDM Pharma Reports First Quarter Financial Results

04/13/2009

IDM Pharma Receives Nasdaq Shareholder Equity Notification
 

News Archive >>